by Jeffrey Stamberger | Oct 10, 2019 | Media Coverage
Medical Marijuana, Inc. and our family of companies made headlines this week for our work bringing CBD to patients in Mexico, our research into cannabinoids, our top quality CBD products, and more. The cannabis and CBD industries continue to dominate the news cycle...
by Jeffrey Stamberger | Aug 24, 2019 | Media Coverage
The development of new cannabinoid products, expanded Medical Marijuana, Inc. operations, CBD reviews, and advocating for hemp in Europe are just some of our top headlines from this week. Medical Marijuana, Inc. and our portfolio of companies, brands, and investments...
by Jeffrey Stamberger | Aug 13, 2019 | Media Coverage
SAN DIEGO, Aug. 12, 2019 — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that the...
by Jeffrey Stamberger | Jun 17, 2019 | Kannaway, Media Coverage
CBD and potential FDA regulation, CBD in Europe, and CBD disrupting the direct selling market lead our company headlines this week. Medical Marijuana, Inc. and our family of companies were at the center of numerous news stories this week as our efforts to expand...
by Jeffrey Stamberger | Jun 17, 2019 | Kannaway, Media Coverage
CBD UND EINE MÖGLICHE REGULIERUNG DER FDA, CBD IN EUROPA UND CBD, DIE DEN DIREKTVERTRIEBSMARKT STÖRT, FÜHREN DIESE WOCHE DIE SCHLAGZEILEN UNSERES UNTERNEHMENS AN. Medical Marijuana, Inc. und unsere Unternehmensfamilie standen im Mittelpunkt zahlreicher Nachrichten in...
by Jeffrey Stamberger | May 9, 2019 | Media Coverage
CBD education for doctors, CBD cat treats, and becoming a top 100 global company lead Medical Marijuana, Inc. headlines this week. As CBD continues to trend as a topic among major media outlets, the Medical Marijuana, Inc. portfolio of companies received coverage from...
